Divis Laboratories Ltd | DIVI - Ordinary Share Capital


Divis Laboratories Ltd reported INR265.47M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Aurobindo Pharma INR 580.8M 0 Mar/2026
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Lupin INR 456.76M 456.44M Sep/2025
Moderna USD 391M 2M Sep/2025
Organon & Co USD 260.32M 333K Dec/2025
Revvity USD 111.8M 1.57M Mar/2026
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Tilray USD 116.52M 5.01M Sep/2025
Viatris USD 1.16B 5.27M Mar/2026
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025